MODULATION OF HEPATITIS B VIRUS CCCDNA TRANSCRIPTION
申请人:Drexel University
公开号:EP2854832A2
公开(公告)日:2015-04-08
[EN] MODULATION OF HEPATITIS B VIRUS CCCDNA TRANSCRIPTION<br/>[FR] MODULATION DE TRANSCRIPTION D'ADNCCC DU VIRUS DE L'HÉPATITE B
申请人:GUO JU TAO
公开号:WO2013181584A2
公开(公告)日:2013-12-05
The present disclosure pertains to the discovery of a new family of "first in class" small molecular inhibitors of hepatitis B virus (HBV) covalently closed circular (ccc) DNA for use as therapeutics in the management of chronic HBV. Provided are agents that provide epigenetic modification of the cccDNA, histone modifying agent, and inhibitors of histone deacetylace activity that in turn modulate HBV cccDNA, which has never been achieved with a pharmacological agent. Also provided are methods for modulating HBV cccDNA, for treating or preventing HBV in a subject, and for modulating cccDNA transcription of hepatitis B in a subject.